Searched for
PHARMACEUTICAL EXPORTS DATA
Drug formulations & biologicals keep India's pharma exports healthy in Q1During the first quarter of fiscal 2027, India's pharmaceutical exports soared to $8.10 billion, showcasing remarkable strength in drug for...- Govt tightens drug quality net, initiates 950 actions since 2022: Over 1,100 cough syrup makers are also facing intensive audits amid quality concernsThe government has initiated 950 enforcement actions against pharmaceutical companies since December 2022. These actions aim to improve the...
- Parliament roundup: Trade pact talks, supply chains, jobs and agriculture in focusTextiles and apparel exports are projected to reach 3.3 lakh crore by FY26. Tobacco product exports saw significant growth in quantity and ...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- India's big billion-dollar trade deals are done. Now comes the real testIndia has spent years negotiating free trade agreements with some of the world's biggest economies. But signing the deals was only half the...
- Uzbekistan invites Indian firms for mining, minerals push ahead of PM Modi's visitIn a bid to enhance economic ties, Uzbekistan is inviting Indian investments into its mining and metallurgy sectors, highlighting lucrative...
- ETMarkets Smart Talk| Large caps offer stability, but alpha lies in selective mid- and small-caps: Rakesh VyasWhile the near-term outlook remains clouded by inflation concerns and margin pressures, Rakesh Vyas, CIO & Portfolio Manager at Quest Inves...
- Govt weighs PLI 2.0 with sharper focus on high-performing sectorsIndia is planning a second phase for its production-linked incentive programme. This new phase will support high-performing sectors and red...
- India's exports from SEZs up 11.8% in 2025-26: GovtExports from special economic zones experienced a remarkable boost in 2025-26, eclipsing USD 185 billion. The pharmaceutical industry also ...
- Trade deals open new markets for Indian medical device makers, but import risks remain: AiMeDThe EU offers the biggest long-term opportunity for Indian medical device makers, while the UK has more immediate strategic value, says AiM...
- Private equity firm Creador in talks to buy into generic drug co Leeford HealthPrivate equity firm Creador is in advanced talks to acquire a stake. The firm expects to invest ₹800 crore in Leeford Healthcare. This acqu...
- The ethanol story is changing. Is investing in the ecosystem the better way? 15 stocks across different market cap segmentsThe ethanol story started simply enough: Cut India's dependence on imported crude oil. It would save foreign exchange. Give farmers a new a...
- India ready for a premium wealth show while US missiles rattle the worldIndia's festive shopping season is set to highlight the country's premiumisation boom despite global uncertainty triggered by the US-Iran w...
- Sankaran Naren favours banks, power as oil risks loomSankaran Naren, CIO of ICICI Prudential Asset Management, remains bullish on banks, power utilities, oil refiners and pharmaceuticals, citi...
- Gujarat industry seeks easier access to incentives, lower cost of doing businessIndustry stakeholders say the opportunity for them lies in strengthening the link between its large industrial base and MSMEs while reducin...
- Pharma mutual funds top return charts across horizons. Should investors chase the rally or stay cautious?Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...
- Food products lead PLI job creation, outpace electronics and pharmaFood processing leads PLI employment, creating jobs with minimal investment. Electronics manufacturing attracted significant capital but ge...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
Load More
